Free Trial
NYSE:MED

Medifast (MED) Stock Price, News & Analysis

Medifast logo
$18.39
-0.30 (-1.61%)
(As of 10/31/2024 ET)

About Medifast Stock (NYSE:MED)

Key Stats

Today's Range
$17.89
$18.75
50-Day Range
$17.31
$19.98
52-Week Range
$17.07
$76.42
Volume
162,505 shs
Average Volume
392,483 shs
Market Capitalization
$201.13 million
P/E Ratio
6.86
Dividend Yield
N/A
Price Target
$17.50
Consensus Rating
Sell

Company Overview

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Medifast Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
33rd Percentile Overall Score

MED MarketRank™: 

Medifast scored higher than 33% of companies evaluated by MarketBeat, and ranked 119th out of 143 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medifast has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Medifast has received no research coverage in the past 90 days.

  • Read more about Medifast's stock forecast and price target.
  • Earnings Growth

    Earnings for Medifast are expected to decrease by -16.07% in the coming year, from $1.12 to $0.94 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medifast is 6.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medifast is 6.86, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 21.90.

  • Price to Book Value per Share Ratio

    Medifast has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Medifast's valuation and earnings.
  • Percentage of Shares Shorted

    16.68% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in Medifast has recently decreased by 3.80%, indicating that investor sentiment is improving.
  • Dividend Yield

    Medifast does not currently pay a dividend.

  • Dividend Growth

    Medifast does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Medifast is 246.27%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on EPS estimates, Medifast will have a dividend payout ratio of 702.13% in the coming year. This indicates that Medifast may not be able to sustain their current dividend.

  • Read more about Medifast's dividend.
  • Percentage of Shares Shorted

    16.68% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 7.4.
  • Change versus previous month

    Short interest in Medifast has recently decreased by 3.80%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Medifast this week, compared to 4 articles on an average week.
  • Search Interest

    Only 5 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Medifast to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medifast insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.50% of the stock of Medifast is held by insiders.

  • Percentage Held by Institutions

    95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medifast's insider trading history.
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

Orano Announces Leadership Transition in Orano Med
The real reason Elon is fully endorsing Trump
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
See More Headlines

MED Stock Analysis - Frequently Asked Questions

Medifast's stock was trading at $67.22 at the start of the year. Since then, MED shares have decreased by 72.7% and is now trading at $18.38.
View the best growth stocks for 2024 here
.

Medifast, Inc. (NYSE:MED) released its quarterly earnings results on Monday, August, 5th. The specialty retailer reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.56. The specialty retailer had revenue of $168.56 million for the quarter, compared to analyst estimates of $160.44 million. Medifast had a net margin of 3.81% and a trailing twelve-month return on equity of 25.77%.

Top institutional shareholders of Medifast include Values First Advisors Inc. (0.59%), Inspire Investing LLC (0.45%), Robeco Institutional Asset Management B.V. (0.19%) and SG Americas Securities LLC (0.10%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends
.

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
8/05/2024
Today
10/31/2024
Next Earnings (Confirmed)
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Miscellaneous food preparations & kindred products
Sub-Industry
Personal Products
CUSIP
58470H10
Employees
870
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.50
High Stock Price Target
$17.50
Low Stock Price Target
$17.50
Potential Upside/Downside
-5.4%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$99.42 million
Pretax Margin
4.84%

Debt

Sales & Book Value

Annual Sales
$1.07 billion
Cash Flow
$11.48 per share
Book Value
$18.50 per share

Miscellaneous

Free Float
10,664,000
Market Cap
$202.28 million
Optionable
Optionable
Beta
1.13

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NYSE:MED) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners